GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
51.99
-0.97 (-1.83%)
Aug 10, 2026, 1:23 PM EDT - Market open

GSK Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
106,01398,38869,01075,09975,71995,027
Market Cap Growth
42.00%42.57%-8.11%-0.82%-20.32%19.88%
Enterprise Value
125,876117,07084,70890,73690,972121,848
Last Close Price
51.9949.0433.8237.0335.1344.10
PE Ratio
16.5713.1421.6712.133.9615.07
PS Ratio
2.412.241.751.952.132.85
PB Ratio
4.654.474.024.425.91-
P/FCF Ratio
11.3611.4410.6710.8210.0010.04
P/OCF Ratio
9.419.458.398.728.458.84
EV/Sales Ratio
2.862.662.152.352.563.65
EV/EBITDA Ratio
14.398.5010.277.898.7613.91
EV/EBIT Ratio
14.3910.9816.7910.5711.6920.69
EV/FCF Ratio
13.4913.6213.1013.0712.0112.87
Debt / Equity Ratio
0.810.921.121.191.690.96
Debt / EBITDA Ratio
2.821.732.591.992.453.73
Debt / FCF Ratio
2.192.773.303.303.353.45
Net Debt / Equity Ratio
0.860.870.960.961.24-
Net Debt / EBITDA Ratio
2.341.401.991.421.533.06
Net Debt / FCF Ratio
1.822.242.542.352.092.83
Asset Turnover
0.540.540.530.510.420.31
Inventory Turnover
1.481.561.621.611.751.39
Quick Ratio
0.520.520.520.610.670.54
Current Ratio
0.820.820.780.880.910.79
Return on Equity (ROE)
31.77%43.31%22.80%46.38%31.31%16.68%
Return on Assets (ROA)
9.38%11.18%5.76%9.91%8.08%5.34%
Return on Invested Capital (ROIC)
17.64%23.88%13.17%24.18%17.47%10.29%
Return on Capital Employed (ROCE)
16.18%20.47%10.62%17.92%13.87%7.66%
Earnings Yield
6.03%7.61%4.62%8.24%25.23%6.63%
FCF Yield
8.80%8.74%9.37%9.25%10.00%9.96%
Dividend Yield
3.40%3.47%4.45%3.81%5.93%6.13%
Payout Ratio
56.46%44.86%94.91%45.60%23.18%91.20%
Buyback Yield / Dilution
1.36%0.60%-0.75%-0.66%-0.79%-0.55%
Total Shareholder Return
4.76%4.07%3.69%3.15%5.14%5.58%
SEC Filings: 10-K · 10-Q